US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Verrica Pharmaceuticals Inc.

6.91

0.0000

Volume:116.04K

Turnover:807.59K

Market Cap:110.49M

PE:-2.34

High:7.15

Open:6.92

Low:6.71

Close:6.91

52wk High:9.82

52wk Low:3.28

Shares:15.99M

Float Shares:1.94M

Volume Ratio:0.67

T/O Rate:6.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.9552

EPS(LYR):-14.7812

ROE:-1546.58%

ROA:-26.28%

PB:-6.48

PE(LYR):-0.47

Loading ...

Overview Company News Filings

Verrica Pharmaceuticals Launches YCANTH in Japan with Torii Pharmaceutical

Verrica Pharmaceuticals Announces Launch of Ycanth® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical

THOMSON REUTERS

Verrica Pharmaceuticals Files Initial Beneficial Ownership Statement for BKB Growth Investments

BRIEF-Verrica Pharmaceuticals Announces First Patient Dosed In Phase 3 Program

Verrica Pharmaceuticals Doses First Patient in Phase 3 Trial of YCANTH for Common Warts

Verrica Pharmaceuticals Inc - Torii to Fund First $40 Mln of Phase 3 Trial Costs

THOMSON REUTERS

Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating Ycanth® (Vp-102) for the Treatment of Common Warts

THOMSON REUTERS

Verrica Pharmaceuticals Files Initial Beneficial Ownership Statement for Director Charles Frantzreb

Verrica Pharmaceuticals Grants New Equity Awards to Executives Under 2018 Plan

Top Premarket Decliners

MT Newswires Live

Verrica Pharmaceuticals CMO Noah L. Rosenberg Acquires Common Shares

Director and 10% Owner Paul B. Manning Reports Acquisition of Verrica Pharmaceuticals Inc. Common Shares

Verrica Pharmaceuticals CEO Jayson Rieger Reports Acquisition of Common Shares

Interim CFO John J. Kirby Acquires Common Shares of Verrica Pharmaceuticals Inc

BRIEF-Verrica Pharmaceuticals Enters Securities Purchase Agreement With Institutional Investors

Verrica Pharmaceuticals Inc - Enters Securities Purchase Agreement With Institutional Investors - SEC Filing

THOMSON REUTERS

Verrica Pharmaceuticals Inc - to Sell 6.5 Mln Shares in Private Placement - SEC Filing

THOMSON REUTERS

Verrica Pharmaceuticals Raises $50 Million in Private Placement Financing

Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway

THOMSON REUTERS

Lytix Biopharma reports promising clinical results for ruxotemitide in melanoma and basal cell carcinoma

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VRCA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VRCA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRCA\",,,,,undefined,":{"symbol":"VRCA","market":"US","secType":"STK","nameCN":"Verrica Pharmaceuticals Inc.","latestPrice":6.91,"timestamp":1770670800000,"preClose":6.91,"halted":0,"volume":116038,"delay":0,"changeRate":0,"floatShares":1935557,"shares":15989861,"eps":-2.955175,"marketStatus":"Pre-Mkt","change":0,"latestTime":"02-10 05:12:01 EST","open":6.92,"high":7.15,"low":6.71,"amount":807586.9649146,"amplitude":0.063676,"askPrice":8,"askSize":5,"bidPrice":2.77,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.955175,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1529035200000,"exchange":"NASDAQ","adjPreClose":6.91,"postHourTrading":{"tag":"盘后","latestPrice":6.83,"preClose":6.91,"latestTime":"18:54 EST","volume":529,"amount":3616.04,"timestamp":1770681248533,"change":-0.08,"changeRate":-0.011577,"amplitude":0.011577},"volumeRatio":0.6673483653395621,"impliedVol":0.3196,"impliedVolPercentile":0.5929},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRCA\",,,,,undefined,":{"symbol":"VRCA","floatShares":1935557,"roa":"-26.28%","roe":"-1546.58%","lyrEps":-14.781242,"volumeRatio":0.6673483653395621,"shares":15989861,"dividePrice":0,"high":7.15,"amplitude":0.063676,"preClose":6.91,"low":6.71,"week52Low":3.28,"pbRate":"-6.48","psRate":"3.58","week52High":9.8212,"institutionHeld":0,"latestPrice":6.91,"committee":0.95122,"eps":-2.955175,"divideRate":0,"volume":116038,"delay":0,"ttmEps":-2.955175,"open":6.92,"prevYearClose":8.31,"prevWeekClose":6.91,"prevMonthClose":7.03,"prevQuarterClose":8.31,"fiveDayClose":7.45,"twentyDayClose":7.945,"sixtyDayClose":3.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRCA\",params:#limit:5,,,undefined,":[{"date":"2025-11-14","symbol":"VRCA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763154000000,"name":null,"time":"Post Market","dateTimestamp":1763096400000,"actualEps":null},{"market":"US","date":"2025-08-12","symbol":"VRCA","fiscalQuarterEnding":"2025/06","expectedEps":-0.7,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":0.02},{"market":"US","date":"2025-07-25","symbol":"VRCA","defaultRemindTime":1753450200000,"type":"split","dateTimestamp":1753416000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-05-13","symbol":"VRCA","fiscalQuarterEnding":"2025/03","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2025-03-11","symbol":"VRCA","fiscalQuarterEnding":"2024/12","expectedEps":-0.25,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRCA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRCA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.6,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1766206800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRCA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRCA","date":"2026-02-06","current":-2.338271,"percent":0.560618,"low":-13.801958,"twenty":-8.890146,"median":-4.586033,"eighty":-0.95209,"high":-0.377883,"avg":-5.086429,"sd":3.551714,"marketCap":105692981},"quantilePoints":[{"date":"2021-02-12","current":-9.444932,"twenty":-20.691735,"median":-12.093054,"eighty":-8.007828,"marketCap":352805992},{"date":"2021-02-19","current":-10.317411,"twenty":-20.606701,"median":-12.008831,"eighty":-8.010825,"marketCap":385396575},{"date":"2021-02-26","current":-9.493403,"twenty":-20.571269,"median":-11.965898,"eighty":-8.015899,"marketCap":354616580},{"date":"2021-03-05","current":-8.28783,"twenty":-20.468519,"median":-11.952231,"eighty":-8.046266,"marketCap":353840614},{"date":"2021-03-12","current":-10.256795,"twenty":-20.387027,"median":-11.889494,"eighty":-8.053587,"marketCap":437903626},{"date":"2021-03-19","current":-9.433007,"twenty":-20.174441,"median":-11.801009,"eighty":-8.06169,"marketCap":402732818},{"date":"2021-03-26","current":-8.520381,"twenty":-20.068148,"median":-11.67409,"eighty":-8.071858,"marketCap":363769158},{"date":"2021-04-01","current":-9.865366,"twenty":-19.841389,"median":-11.59076,"eighty":-8.078665,"marketCap":421191933},{"date":"2021-04-09","current":-8.855019,"twenty":-19.689036,"median":-11.524855,"eighty":-8.093693,"marketCap":378056165},{"date":"2021-04-16","current":-8.166438,"twenty":-19.660691,"median":-11.480525,"eighty":-8.122364,"marketCap":348657902},{"date":"2021-04-23","current":-8.711984,"twenty":-19.646519,"median":-11.455341,"eighty":-8.140368,"marketCap":371949441},{"date":"2021-04-30","current":-8.499497,"twenty":-19.62526,"median":-11.384529,"eighty":-8.155602,"marketCap":362877504},{"date":"2021-05-07","current":-9.323537,"twenty":-19.547312,"median":-11.276316,"eighty":-8.093693,"marketCap":315210124},{"date":"2021-05-14","current":-9.485685,"twenty":-19.504794,"median":-11.133771,"eighty":-8.122364,"marketCap":320692039},{"date":"2021-05-21","current":-9.201925,"twenty":-19.345355,"median":-11.069937,"eighty":-8.140368,"marketCap":311098687},{"date":"2021-05-28","current":-9.128958,"twenty":-19.239062,"median":-11.021311,"eighty":-8.155602,"marketCap":308631825},{"date":"2021-06-04","current":-7.920952,"twenty":-19.210717,"median":-11.012373,"eighty":-8.11544,"marketCap":267791557},{"date":"2021-06-11","current":-8.504687,"twenty":-19.132769,"median":-10.940895,"eighty":-8.138983,"marketCap":287526452},{"date":"2021-06-18","current":-9.380289,"twenty":-18.874122,"median":-10.892695,"eighty":-8.151447,"marketCap":317128794},{"date":"2021-06-25","current":-9.266785,"twenty":-18.558786,"median":-10.868389,"eighty":-8.164922,"marketCap":313291453},{"date":"2021-07-02","current":-9.364074,"twenty":-18.548156,"median":-10.785238,"eighty":-8.166438,"marketCap":316580602},{"date":"2021-07-09","current":-8.407398,"twenty":-18.54107,"median":-10.67511,"eighty":-8.175627,"marketCap":284237303},{"date":"2021-07-16","current":-8.334431,"twenty":-18.502096,"median":-10.653174,"eighty":-8.216537,"marketCap":281770441},{"date":"2021-07-23","current":-8.569546,"twenty":-18.434776,"median":-10.578686,"eighty":-8.236089,"marketCap":289719218},{"date":"2021-07-30","current":-8.674943,"twenty":-18.332027,"median":-10.561182,"eighty":-8.249241,"marketCap":293282463},{"date":"2021-08-06","current":-8.593868,"twenty":-18.317854,"median":-10.529864,"eighty":-8.255232,"marketCap":290541505},{"date":"2021-08-13","current":-8.169074,"twenty":-18.303682,"median":-10.515423,"eighty":-8.236089,"marketCap":295508092},{"date":"2021-08-20","current":-7.492121,"twenty":-18.229276,"median":-10.48706,"eighty":-8.166438,"marketCap":271019992},{"date":"2021-08-27","current":-8.420079,"twenty":-18.158414,"median":-10.428202,"eighty":-8.164416,"marketCap":304587950},{"date":"2021-09-03","current":-10.618275,"twenty":-18.147785,"median":-10.414533,"eighty":-8.166438,"marketCap":384105491},{"date":"2021-09-10","current":-9.165488,"twenty":-18.105268,"median":-10.360513,"eighty":-8.166438,"marketCap":331552376},{"date":"2021-09-17","current":-9.256763,"twenty":-18.087552,"median":-10.317411,"eighty":-8.169074,"marketCap":334854142},{"date":"2021-09-24","current":-8.754753,"twenty":-17.786388,"median":-10.276924,"eighty":-8.212382,"marketCap":316694427},{"date":"2021-10-01","current":-9.515374,"twenty":-17.715526,"median":-10.222565,"eighty":-8.233156,"marketCap":344209147},{"date":"2021-10-08","current":-9.439312,"twenty":-17.573802,"median":-10.190534,"eighty":-8.247819,"marketCap":341457675},{"date":"2021-10-15","current":-10.161902,"twenty":-17.520656,"median":-10.161902,"eighty":-8.254927,"marketCap":367596659},{"date":"2021-10-22","current":-9.713136,"twenty":-17.006905,"median":-10.125651,"eighty":-8.256454,"marketCap":351362974},{"date":"2021-10-29","current":-9.576224,"twenty":-16.210213,"median":-10.103591,"eighty":-8.274702,"marketCap":346410324},{"date":"2021-11-05","current":-10.017384,"twenty":-16.174276,"median":-10.087097,"eighty":-8.28783,"marketCap":362368862},{"date":"2021-11-12","current":-8.809355,"twenty":-16.065695,"median":-10.077527,"eighty":-8.288551,"marketCap":339309923},{"date":"2021-11-19","current":-8.173481,"twenty":-16.06081,"median":-10.059534,"eighty":-8.28783,"marketCap":314817966},{"date":"2021-11-26","current":-7.473305,"twenty":-15.941288,"median":-10.041766,"eighty":-8.253505,"marketCap":287849294},{"date":"2021-12-03","current":-6.615947,"twenty":-15.702243,"median":-10.020775,"eighty":-8.1726,"marketCap":254826430},{"date":"2021-12-10","current":-6.987469,"twenty":-15.573376,"median":-10.010115,"eighty":-8.159756,"marketCap":269136338},{"date":"2021-12-17","current":-6.501633,"twenty":-15.554232,"median":-10.002172,"eighty":-8.101396,"marketCap":250423382},{"date":"2021-12-23","current":-6.737406,"twenty":-15.545879,"median":-9.957163,"eighty":-8.078665,"marketCap":259504669},{"date":"2021-12-31","current":-6.5445,"twenty":-15.404401,"median":-9.905662,"eighty":-8.050103,"marketCap":252074525},{"date":"2022-01-07","current":-6.480199,"twenty":-15.306325,"median":-9.880472,"eighty":-8.005508,"marketCap":249597810},{"date":"2022-01-14","current":-5.94435,"twenty":-15.155456,"median":-9.873556,"eighty":-7.967,"marketCap":228958520},{"date":"2022-01-21","current":-5.537105,"twenty":-15.045894,"median":-9.865313,"eighty":-7.935851,"marketCap":213272660},{"date":"2022-01-28","current":-5.43708,"twenty":-15.02557,"median":-9.832701,"eighty":-7.874921,"marketCap":209419993},{"date":"2022-02-04","current":-5.587117,"twenty":-15.00857,"median":-9.792473,"eighty":-7.845703,"marketCap":215198994},{"date":"2022-02-11","current":-5.887193,"twenty":-14.96848,"median":-9.783278,"eighty":-7.809671,"marketCap":226756996},{"date":"2022-02-18","current":-5.644274,"twenty":-14.936962,"median":-9.765677,"eighty":-7.717235,"marketCap":217400518},{"date":"2022-02-25","current":-5.758589,"twenty":-14.896984,"median":-9.762103,"eighty":-7.561149,"marketCap":221803567},{"date":"2022-03-04","current":-6.38555,"twenty":-14.755152,"median":-9.755823,"eighty":-7.515219,"marketCap":224005091},{"date":"2022-03-11","current":-6.181589,"twenty":-14.745783,"median":-9.737752,"eighty":-7.481244,"marketCap":216850137},{"date":"2022-03-18","current":-6.754249,"twenty":-14.723661,"median":-9.713136,"eighty":-7.424792,"marketCap":236939046},{"date":"2022-03-25","current":-6.542443,"twenty":-14.660984,"median":-9.687818,"eighty":-7.341298,"marketCap":229508902},{"date":"2022-04-01","current":-6.652268,"twenty":-14.645285,"median":-9.674618,"eighty":-7.270396,"marketCap":233361569},{"date":"2022-04-08","current":-6.887608,"twenty":-14.640589,"median":-9.665964,"eighty":-7.202806,"marketCap":241617285},{"date":"2022-04-14","current":-6.212967,"twenty":-14.637019,"median":-9.648308,"eighty":-7.123217,"marketCap":217950899},{"date":"2022-04-22","current":-5.726599,"twenty":-14.637019,"median":-9.621861,"eighty":-7.033623,"marketCap":200889086},{"date":"2022-04-29","current":-5.153939,"twenty":-14.480326,"median":-9.575546,"eighty":-7.002293,"marketCap":180800178},{"date":"2022-05-06","current":-4.816619,"twenty":-14.461891,"median":-9.561011,"eighty":-6.987469,"marketCap":168966985},{"date":"2022-05-13","current":-3.655086,"twenty":-14.438154,"median":-9.538384,"eighty":-6.96313,"marketCap":155757839},{"date":"2022-05-20","current":-3.835903,"twenty":-14.425022,"median":-9.508724,"eighty":-6.931361,"marketCap":163463174},{"date":"2022-05-27","current":-1.29155,"twenty":-14.39737,"median":-9.496783,"eighty":-6.895453,"marketCap":55038106},{"date":"2022-06-03","current":-1.465909,"twenty":-14.373536,"median":-9.485685,"eighty":-6.879432,"marketCap":62468250},{"date":"2022-06-10","current":-1.356127,"twenty":-14.325047,"median":-9.469488,"eighty":-6.861307,"marketCap":57790011},{"date":"2022-06-17","current":-1.452994,"twenty":-14.292293,"median":-9.460652,"eighty":-6.808853,"marketCap":61917869},{"date":"2022-06-24","current":-1.362585,"twenty":-14.264642,"median":-9.453534,"eighty":-6.788739,"marketCap":58065201},{"date":"2022-07-01","current":-2.012398,"twenty":-14.233303,"median":-9.439312,"eighty":-6.769114,"marketCap":85756345},{"date":"2022-07-08","current":-3.199435,"twenty":-14.196357,"median":-9.43704,"eighty":-6.737867,"marketCap":136340732},{"date":"2022-07-15","current":-3.095506,"twenty":-14.146545,"median":-9.427646,"eighty":-6.720845,"marketCap":131911910},{"date":"2022-07-22","current":-2.98943,"twenty":-14.126383,"median":-9.420826,"eighty":-6.650804,"marketCap":127391564},{"date":"2022-07-29","current":-3.037646,"twenty":-14.11343,"median":-9.393106,"eighty":-6.6457,"marketCap":129446266},{"date":"2022-08-05","current":-3.259443,"twenty":-14.098659,"median":-9.386069,"eighty":-6.629464,"marketCap":138897899},{"date":"2022-08-12","current":-4.048576,"twenty":-14.089457,"median":-9.372181,"eighty":-6.615947,"marketCap":166019974},{"date":"2022-08-19","current":-3.407218,"twenty":-14.080212,"median":-9.36325,"eighty":-6.60378,"marketCap":139719780},{"date":"2022-08-26","current":-3.707855,"twenty":-14.074766,"median":-9.323537,"eighty":-6.587248,"marketCap":152047996},{"date":"2022-09-02","current":-3.948364,"twenty":-14.072368,"median":-9.298233,"eighty":-6.568162,"marketCap":161910568},{"date":"2022-09-09","current":-4.108704,"twenty":-14.068127,"median":-9.293402,"eighty":-6.548507,"marketCap":168485617},{"date":"2022-09-16","current":-3.607642,"twenty":-14.065549,"median":-9.287796,"eighty":-6.536167,"marketCap":147938590},{"date":"2022-09-23","current":-2.886114,"twenty":-14.063705,"median":-9.273837,"eighty":-6.523501,"marketCap":118350872},{"date":"2022-09-30","current":-2.926199,"twenty":-14.054478,"median":-9.269303,"eighty":-6.510959,"marketCap":119994634},{"date":"2022-10-07","current":-2.435159,"twenty":-14.038958,"median":-9.256763,"eighty":-6.47805,"marketCap":99858548},{"date":"2022-10-14","current":-2.735795,"twenty":-14.005422,"median":-9.237861,"eighty":-6.42674,"marketCap":112186764},{"date":"2022-10-21","current":-2.405095,"twenty":-13.997341,"median":-9.233944,"eighty":-6.407981,"marketCap":98625727},{"date":"2022-10-28","current":-2.425137,"twenty":-13.971532,"median":-9.225586,"eighty":-6.34789,"marketCap":99447608},{"date":"2022-11-04","current":-2.294861,"twenty":-13.919916,"median":-9.203519,"eighty":-6.323973,"marketCap":94105381},{"date":"2022-11-11","current":-3.45193,"twenty":-13.888612,"median":-9.197563,"eighty":-6.255329,"marketCap":96981965},{"date":"2022-11-18","current":-3.539691,"twenty":-13.879534,"median":-9.165488,"eighty":-6.211558,"marketCap":99447608},{"date":"2022-11-25","current":-3.788347,"twenty":-13.872169,"median":-9.151804,"eighty":-6.15021,"marketCap":106433597},{"date":"2022-12-02","current":-4.914612,"twenty":-13.871986,"median":-9.14739,"eighty":-6.10155,"marketCap":138076018},{"date":"2022-12-09","current":-4.519688,"twenty":-13.837527,"median":-9.128958,"eighty":-6.040385,"marketCap":126980623},{"date":"2022-12-16","current":-4.344166,"twenty":-13.816682,"median":-9.113473,"eighty":-6.010411,"marketCap":122049337},{"date":"2022-12-23","current":-3.671332,"twenty":-13.816682,"median":-9.097752,"eighty":-5.987218,"marketCap":103146073},{"date":"2022-12-30","current":-4.022376,"twenty":-13.809189,"median":-9.072206,"eighty":-5.975782,"marketCap":113008645},{"date":"2023-01-06","current":-5.675206,"twenty":-13.790814,"median":-9.048839,"eighty":-5.963696,"marketCap":159444925},{"date":"2023-01-13","current":-7.094008,"twenty":-13.774283,"median":-9.048276,"eighty":-5.966499,"marketCap":199306157},{"date":"2023-01-20","current":-6.070131,"twenty":-13.766909,"median":-9.029872,"eighty":-5.967544,"marketCap":170540319},{"date":"2023-01-27","current":-6.889233,"twenty":-13.761379,"median":-9.007347,"eighty":-5.972089,"marketCap":193552989},{"date":"2023-02-03","current":-7.664454,"twenty":-13.754146,"median":-8.998696,"eighty":-5.979662,"marketCap":215332837},{"date":"2023-02-10","current":-10.385043,"twenty":-13.739615,"median":-8.99924,"eighty":-5.983253,"marketCap":291767776},{"date":"2023-02-17","current":-11.584442,"twenty":-13.733946,"median":-9.009597,"eighty":-5.985324,"marketCap":325464899},{"date":"2023-02-24","current":-11.974593,"twenty":-13.731884,"median":-9.029872,"eighty":-5.987218,"marketCap":336426186},{"date":"2023-03-03","current":-10.73841,"twenty":-13.720823,"median":-9.048668,"eighty":-5.990491,"marketCap":301695622},{"date":"2023-03-10","current":-11.21205,"twenty":-13.704314,"median":-9.057958,"eighty":-6.004597,"marketCap":274549467},{"date":"2023-03-17","current":-11.998261,"twenty":-13.69687,"median":-9.078186,"eighty":-6.009004,"marketCap":293801412},{"date":"2023-03-24","current":-11.160775,"twenty":-13.691896,"median":-9.102099,"eighty":-6.013181,"marketCap":273293906},{"date":"2023-03-31","current":-11.109501,"twenty":-13.676811,"median":-9.124348,"eighty":-6.024347,"marketCap":272038344},{"date":"2023-04-06","current":-10.340381,"twenty":-13.670364,"median":-9.142652,"eighty":-6.024696,"marketCap":253204920},{"date":"2023-04-14","current":-10.76767,"twenty":-13.669206,"median":-9.149196,"eighty":-6.03254,"marketCap":263667933},{"date":"2023-04-21","current":-10.528388,"twenty":-13.650772,"median":-9.161388,"eighty":-6.040385,"marketCap":257808646},{"date":"2023-04-28","current":-10.135283,"twenty":-13.633013,"median":-9.181896,"eighty":-6.062388,"marketCap":248182674},{"date":"2023-05-05","current":-10.955677,"twenty":-13.632835,"median":-9.201925,"eighty":-6.062388,"marketCap":268271659},{"date":"2023-05-12","current":-11.756195,"twenty":-13.632337,"median":-9.224245,"eighty":-6.070131,"marketCap":265760536},{"date":"2023-05-19","current":-10.97862,"twenty":-13.62363,"median":-9.232771,"eighty":-6.093505,"marketCap":248182674},{"date":"2023-05-26","current":-10.849024,"twenty":-13.620563,"median":-9.234057,"eighty":-6.10155,"marketCap":245253030},{"date":"2023-06-02","current":-10.552805,"twenty":-13.615653,"median":-9.247013,"eighty":-6.114083,"marketCap":238556702},{"date":"2023-06-09","current":-10.552805,"twenty":-13.614007,"median":-9.264369,"eighty":-6.118509,"marketCap":238556702},{"date":"2023-06-16","current":-11.608085,"twenty":-13.590351,"median":-9.271821,"eighty":-6.127261,"marketCap":262412372},{"date":"2023-06-23","current":-11.348893,"twenty":-13.555269,"median":-9.269303,"eighty":-6.124452,"marketCap":256553084},{"date":"2023-06-30","current":-10.663887,"twenty":-13.492373,"median":-9.266785,"eighty":-6.121642,"marketCap":241067825},{"date":"2023-07-07","current":-10.793483,"twenty":-13.458555,"median":-9.266785,"eighty":-6.121642,"marketCap":243997468},{"date":"2023-07-14","current":-12.792961,"twenty":-13.409279,"median":-9.266785,"eighty":-6.121642,"marketCap":289197686},{"date":"2023-07-21","current":-13.292831,"twenty":-13.327224,"median":-9.266785,"eighty":-6.121642,"marketCap":300497740},{"date":"2023-07-28","current":-9.590093,"twenty":-13.290873,"median":-9.266785,"eighty":-6.121642,"marketCap":216793634},{"date":"2023-08-04","current":-9.849284,"twenty":-13.221364,"median":-9.266785,"eighty":-6.121642,"marketCap":222652921},{"date":"2023-08-11","current":-9.581818,"twenty":-13.103509,"median":-9.264369,"eighty":-6.121642,"marketCap":224482838},{"date":"2023-08-18","current":-8.220663,"twenty":-13.051899,"median":-9.23417,"eighty":-6.121642,"marketCap":192593687},{"date":"2023-08-25","current":-7.808734,"twenty":-12.975777,"median":-9.224924,"eighty":-6.121642,"marketCap":182943023},{"date":"2023-09-01","current":-8.149023,"twenty":-12.885999,"median":-9.197563,"eighty":-6.121642,"marketCap":190915310},{"date":"2023-09-08","current":-7.486355,"twenty":-12.87598,"median":-9.161388,"eighty":-6.121642,"marketCap":175390329},{"date":"2023-09-15","current":-7.540085,"twenty":-12.821585,"median":-9.142652,"eighty":-6.121642,"marketCap":176649111},{"date":"2023-09-22","current":-6.716228,"twenty":-12.731741,"median":-9.099561,"eighty":-6.121642,"marketCap":157347783},{"date":"2023-09-29","current":-6.805777,"twenty":-12.614132,"median":-9.06243,"eighty":-6.121642,"marketCap":159445754},{"date":"2023-10-06","current":-7.056517,"twenty":-12.464757,"median":-9.042033,"eighty":-6.118832,"marketCap":165320071},{"date":"2023-10-13","current":-6.537128,"twenty":-12.44537,"median":-8.99924,"eighty":-6.118832,"marketCap":153151842},{"date":"2023-10-20","current":-6.340119,"twenty":-12.38566,"median":-8.968705,"eighty":-6.118832,"marketCap":148536307},{"date":"2023-10-27","current":-6.286389,"twenty":-12.188778,"median":-8.921666,"eighty":-6.117862,"marketCap":147277525},{"date":"2023-11-03","current":-7.092336,"twenty":-12.124264,"median":-8.88076,"eighty":-6.107816,"marketCap":166159259},{"date":"2023-11-10","current":-2.787856,"twenty":-12.053336,"median":-8.855019,"eighty":-6.079481,"marketCap":134689702},{"date":"2023-11-17","current":-3.021216,"twenty":-11.974282,"median":-8.823841,"eighty":-6.033784,"marketCap":145963998},{"date":"2023-11-24","current":-3.291123,"twenty":-11.946973,"median":-8.809355,"eighty":-6.009356,"marketCap":159004010},{"date":"2023-12-01","current":-3.204056,"twenty":-11.792001,"median":-8.772232,"eighty":-5.983253,"marketCap":154797555},{"date":"2023-12-08","current":-3.491376,"twenty":-11.680352,"median":-8.755058,"eighty":-5.963696,"marketCap":168678857},{"date":"2023-12-15","current":-3.273709,"twenty":-11.5949,"median":-8.746737,"eighty":-5.94435,"marketCap":158162719},{"date":"2023-12-22","current":-5.580978,"twenty":-11.531982,"median":-8.733866,"eighty":-5.919137,"marketCap":269633784},{"date":"2023-12-29","current":-6.347165,"twenty":-11.481358,"median":-8.726015,"eighty":-5.897703,"marketCap":306650591},{"date":"2024-01-05","current":-5.833471,"twenty":-11.456718,"median":-8.705341,"eighty":-5.887193,"marketCap":281832505},{"date":"2024-01-12","current":-5.180471,"twenty":-11.382196,"median":-8.657402,"eighty":-5.847771,"marketCap":250284090},{"date":"2024-01-19","current":-5.015044,"twenty":-11.319267,"median":-8.629782,"eighty":-5.815746,"marketCap":242291825},{"date":"2024-01-26","current":-4.927977,"twenty":-11.292577,"median":-8.600502,"eighty":-5.780023,"marketCap":238085369},{"date":"2024-02-02","current":-5.006337,"twenty":-11.199619,"median":-8.585761,"eighty":-5.716494,"marketCap":241871179},{"date":"2024-02-09","current":-4.562297,"twenty":-11.157999,"median":-8.553331,"eighty":-5.660612,"marketCap":220418257},{"date":"2024-02-16","current":-4.840911,"twenty":-11.109501,"median":-8.520481,"eighty":-5.582206,"marketCap":233878914},{"date":"2024-02-23","current":-4.44911,"twenty":-11.107206,"median":-8.503948,"eighty":-5.531389,"marketCap":214949865},{"date":"2024-03-01","current":-3.308907,"twenty":-11.065253,"median":-8.450504,"eighty":-5.425178,"marketCap":221680194},{"date":"2024-03-08","current":-3.077158,"twenty":-11.026791,"median":-8.406267,"eighty":-5.308737,"marketCap":206154167},{"date":"2024-03-15","current":-3.102484,"twenty":-11.012924,"median":-8.370716,"eighty":-5.206723,"marketCap":207850909},{"date":"2024-03-22","current":-3.197458,"twenty":-10.980747,"median":-8.337022,"eighty":-5.168824,"marketCap":214213692},{"date":"2024-03-28","current":-3.577354,"twenty":-10.949764,"median":-8.293845,"eighty":-5.133489,"marketCap":239664824},{"date":"2024-04-05","current":-4.064887,"twenty":-10.882731,"median":-8.255691,"eighty":-5.042905,"marketCap":272327110},{"date":"2024-04-12","current":-4.476441,"twenty":-10.811536,"median":-8.192932,"eighty":-4.983583,"marketCap":299899169},{"date":"2024-04-19","current":-4.368958,"twenty":-10.781343,"median":-8.156467,"eighty":-4.929718,"marketCap":292698365},{"date":"2024-04-26","current":-4.210663,"twenty":-10.745711,"median":-8.101591,"eighty":-4.905516,"marketCap":282093352},{"date":"2024-05-03","current":-4.280313,"twenty":-10.672045,"median":-8.073894,"eighty":-4.840911,"marketCap":286759558},{"date":"2024-05-10","current":-4.96415,"twenty":-10.664627,"median":-8.044877,"eighty":-4.817379,"marketCap":332573215},{"date":"2024-05-17","current":-4.807504,"twenty":-10.664627,"median":-8.011574,"eighty":-4.801428,"marketCap":388143484},{"date":"2024-05-24","current":-4.387176,"twenty":-10.664627,"median":-7.970027,"eighty":-4.742525,"marketCap":354207442},{"date":"2024-05-31","current":-4.376668,"twenty":-10.664627,"median":-7.943413,"eighty":-4.651329,"marketCap":353359041},{"date":"2024-06-07","current":-4.613103,"twenty":-10.664627,"median":-7.943413,"eighty":-4.601414,"marketCap":372448065},{"date":"2024-06-14","current":-4.497512,"twenty":-10.664874,"median":-7.900245,"eighty":-4.564052,"marketCap":363115653},{"date":"2024-06-21","current":-3.788208,"twenty":-10.665121,"median":-7.849613,"eighty":-4.534314,"marketCap":305848582},{"date":"2024-06-28","current":-3.793463,"twenty":-10.66865,"median":-7.826644,"eighty":-4.519134,"marketCap":306272782},{"date":"2024-07-05","current":-3.940577,"twenty":-10.650054,"median":-7.808919,"eighty":-4.508021,"marketCap":318150397},{"date":"2024-07-12","current":-4.45548,"twenty":-10.602867,"median":-7.747352,"eighty":-4.497512,"marketCap":359722049},{"date":"2024-07-15","current":-4.476496,"twenty":-10.596755,"median":-7.7222,"eighty":-4.497512,"marketCap":361418851},{"date":"2024-08-02","current":-3.325847,"twenty":-10.578207,"median":-7.559041,"eighty":-4.474894,"marketCap":268518935},{"date":"2024-08-09","current":-2.700609,"twenty":-10.578207,"median":-7.511408,"eighty":-4.445712,"marketCap":218039072},{"date":"2024-08-16","current":-1.428289,"twenty":-10.578207,"median":-7.48442,"eighty":-4.417713,"marketCap":124165489},{"date":"2024-08-23","current":-1.369391,"twenty":-10.578207,"median":-7.414715,"eighty":-4.368398,"marketCap":119045262},{"date":"2024-08-30","current":-1.197604,"twenty":-10.578207,"median":-7.31913,"eighty":-4.342793,"marketCap":104111269},{"date":"2024-09-06","current":-1.020908,"twenty":-10.578207,"median":-7.268599,"eighty":-4.299308,"marketCap":88750590},{"date":"2024-09-13","current":-0.952193,"twenty":-10.57053,"median":-7.199796,"eighty":-4.265299,"marketCap":82776992},{"date":"2024-09-20","current":-0.952193,"twenty":-10.552805,"median":-7.163976,"eighty":-4.203283,"marketCap":82776992},{"date":"2024-09-27","current":-0.824579,"twenty":-10.525337,"median":-7.123217,"eighty":-4.090084,"marketCap":71683169},{"date":"2024-10-04","current":-0.711691,"twenty":-10.4973,"median":-7.056517,"eighty":-4.042507,"marketCap":61869401},{"date":"2024-10-11","current":-0.633159,"twenty":-10.414401,"median":-7.005278,"eighty":-3.999567,"marketCap":55042433},{"date":"2024-10-18","current":-0.716599,"twenty":-10.343336,"median":-6.99446,"eighty":-3.935721,"marketCap":62296087},{"date":"2024-10-25","current":-0.736232,"twenty":-10.290696,"median":-6.962367,"eighty":-3.916296,"marketCap":64002829},{"date":"2024-10-31","current":-0.785314,"twenty":-10.224124,"median":-6.939632,"eighty":-3.906623,"marketCap":68269684},{"date":"2024-11-08","current":-0.377883,"twenty":-10.16594,"median":-6.892343,"eighty":-3.872942,"marketCap":32116639},{"date":"2024-11-15","current":-0.463192,"twenty":-10.108795,"median":-6.877417,"eighty":-3.82734,"marketCap":39367166},{"date":"2024-11-22","current":-0.531171,"twenty":-10.076692,"median":-6.861307,"eighty":-3.788291,"marketCap":45144787},{"date":"2024-11-29","current":-1.363944,"twenty":-10.008707,"median":-6.82911,"eighty":-3.748307,"marketCap":115922995},{"date":"2024-12-06","current":-1.129516,"twenty":-9.958444,"median":-6.798296,"eighty":-3.687233,"marketCap":95998730},{"date":"2024-12-13","current":-0.855236,"twenty":-9.882798,"median":-6.779649,"eighty":-3.610752,"marketCap":72687340},{"date":"2024-12-20","current":-0.720653,"twenty":-9.865302,"median":-6.743758,"eighty":-3.581084,"marketCap":61249001},{"date":"2024-12-27","current":-0.691243,"twenty":-9.849284,"median":-6.732995,"eighty":-3.514038,"marketCap":58749411},{"date":"2025-01-03","current":-0.748678,"twenty":-9.806688,"median":-6.710314,"eighty":-3.484906,"marketCap":63630856},{"date":"2025-01-10","current":-0.745587,"twenty":-9.766379,"median":-6.668233,"eighty":-3.443141,"marketCap":63368218},{"date":"2025-01-17","current":-0.682185,"twenty":-9.757593,"median":-6.64746,"eighty":-3.394029,"marketCap":57979610},{"date":"2025-01-24","current":-0.777875,"twenty":-9.728647,"median":-6.634163,"eighty":-3.357836,"marketCap":66112333},{"date":"2025-01-31","current":-0.764235,"twenty":-9.679607,"median":-6.615947,"eighty":-3.33003,"marketCap":64953103},{"date":"2025-02-07","current":-0.728538,"twenty":-9.627716,"median":-6.602833,"eighty":-3.302322,"marketCap":61919181},{"date":"2025-02-14","current":-0.694653,"twenty":-9.575681,"median":-6.587368,"eighty":-3.285899,"marketCap":59039219},{"date":"2025-02-21","current":-0.790555,"twenty":-9.547301,"median":-6.571503,"eighty":-3.269086,"marketCap":67190054},{"date":"2025-02-28","current":-0.6288,"twenty":-9.504726,"median":-6.5445,"eighty":-3.25033,"marketCap":53442312},{"date":"2025-03-07","current":-0.659169,"twenty":-9.471913,"median":-6.535863,"eighty":-3.205797,"marketCap":56023410},{"date":"2025-03-14","current":-0.708434,"twenty":-9.46119,"median":-6.523067,"eighty":-3.172132,"marketCap":54251153},{"date":"2025-03-21","current":-0.730966,"twenty":-9.46119,"median":-6.505302,"eighty":-3.135359,"marketCap":55976617},{"date":"2025-03-28","current":-0.524344,"twenty":-9.45159,"median":-6.471711,"eighty":-3.095717,"marketCap":40153746},{"date":"2025-04-04","current":-0.50337,"twenty":-9.439312,"median":-6.424459,"eighty":-3.068441,"marketCap":38547597},{"date":"2025-04-11","current":-0.530456,"twenty":-9.431377,"median":-6.38555,"eighty":-3.053997,"marketCap":40621824},{"date":"2025-04-17","current":-0.574322,"twenty":-9.419093,"median":-6.347165,"eighty":-3.027788,"marketCap":43980972},{"date":"2025-04-25","current":-0.559101,"twenty":-9.384913,"median":-6.325743,"eighty":-2.990813,"marketCap":42815366},{"date":"2025-05-02","current":-0.567835,"twenty":-9.330001,"median":-6.290473,"eighty":-2.93622,"marketCap":43484231},{"date":"2025-05-09","current":-0.501308,"twenty":-9.305504,"median":-6.248269,"eighty":-2.852042,"marketCap":38389651},{"date":"2025-05-16","current":-0.899541,"twenty":-9.281378,"median":-6.196397,"eighty":-2.778275,"marketCap":59360719},{"date":"2025-05-23","current":-0.868986,"twenty":-9.266302,"median":-6.118024,"eighty":-2.732134,"marketCap":57344415},{"date":"2025-05-30","current":-0.763727,"twenty":-9.233944,"median":-6.06626,"eighty":-2.68702,"marketCap":50398342},{"date":"2025-06-06","current":-0.817828,"twenty":-9.165249,"median":-6.028618,"eighty":-2.612139,"marketCap":53968494},{"date":"2025-06-13","current":-0.944392,"twenty":-9.144284,"median":-5.995401,"eighty":-2.518608,"marketCap":62320431},{"date":"2025-06-20","current":-0.811241,"twenty":-9.06243,"median":-5.977628,"eighty":-2.425137,"marketCap":53533786},{"date":"2025-06-27","current":-0.816427,"twenty":-8.99924,"median":-5.954094,"eighty":-2.405095,"marketCap":53876003},{"date":"2025-07-03","current":-0.990504,"twenty":-8.97729,"median":-5.94435,"eighty":-2.294861,"marketCap":65363384},{"date":"2025-07-11","current":-1.222888,"twenty":-8.960121,"median":-5.929245,"eighty":-1.478825,"marketCap":80698391},{"date":"2025-07-18","current":-1.198641,"twenty":-8.960121,"median":-5.887193,"eighty":-1.452831,"marketCap":79098297},{"date":"2025-07-24","current":-0.987841,"twenty":-8.960121,"median":-5.850885,"eighty":-1.407789,"marketCap":65187651},{"date":"2025-08-01","current":-0.789096,"twenty":-8.963555,"median":-5.80983,"eighty":-1.382153,"marketCap":52072427},{"date":"2025-08-08","current":-0.856372,"twenty":-8.963555,"median":-5.794312,"eighty":-1.363672,"marketCap":56511994},{"date":"2025-08-15","current":-1.195298,"twenty":-8.963555,"median":-5.794312,"eighty":-1.34192,"marketCap":58091473},{"date":"2025-08-22","current":-1.115611,"twenty":-8.963555,"median":-5.724733,"eighty":-1.266932,"marketCap":54218708},{"date":"2025-08-29","current":-1.078683,"twenty":-8.963555,"median":-5.677369,"eighty":-1.252587,"marketCap":52424012},{"date":"2025-09-05","current":-1.002884,"twenty":-8.966989,"median":-5.644274,"eighty":-1.207787,"marketCap":48740162},{"date":"2025-09-12","current":-0.960125,"twenty":-8.963555,"median":-5.551394,"eighty":-1.192797,"marketCap":46662093},{"date":"2025-09-19","current":-0.785204,"twenty":-8.963555,"median":-5.43708,"eighty":-1.164025,"marketCap":38160902},{"date":"2025-09-26","current":-0.794922,"twenty":-8.963555,"median":-5.315424,"eighty":-1.147146,"marketCap":38633191},{"date":"2025-10-03","current":-0.882382,"twenty":-8.963555,"median":-5.196764,"eighty":-1.129391,"marketCap":42883786},{"date":"2025-10-10","current":-0.835737,"twenty":-8.963555,"median":-5.149792,"eighty":-1.086069,"marketCap":40616802},{"date":"2025-10-17","current":-0.822132,"twenty":-8.963555,"median":-5.045518,"eighty":-1.068425,"marketCap":39955598},{"date":"2025-10-24","current":-0.767712,"twenty":-8.963555,"median":-5.001691,"eighty":-1.020024,"marketCap":37310783},{"date":"2025-10-31","current":-0.686082,"twenty":-8.963555,"median":-4.951178,"eighty":-0.991856,"marketCap":33343561},{"date":"2025-11-07","current":-0.695799,"twenty":-8.963555,"median":-4.919271,"eighty":-0.979561,"marketCap":33815849},{"date":"2025-11-14","current":-0.752163,"twenty":-8.963555,"median":-4.842662,"eighty":-0.956119,"marketCap":36555122},{"date":"2025-11-21","current":-1.466516,"twenty":-8.963555,"median":-4.817569,"eighty":-0.95209,"marketCap":38149940},{"date":"2025-11-28","current":-3.319725,"twenty":-8.963555,"median":-4.80244,"eighty":-0.95209,"marketCap":86359318},{"date":"2025-12-05","current":-3.071657,"twenty":-8.963555,"median":-4.74296,"eighty":-0.95209,"marketCap":79906094},{"date":"2025-12-12","current":-5.101709,"twenty":-8.963555,"median":-4.74296,"eighty":-0.95209,"marketCap":132715846},{"date":"2025-12-19","current":-4.984922,"twenty":-8.963555,"median":-4.721194,"eighty":-0.95209,"marketCap":129677772},{"date":"2025-12-26","current":-5.120148,"twenty":-8.963555,"median":-4.721194,"eighty":-0.95209,"marketCap":133195542},{"date":"2026-01-02","current":-5.107855,"twenty":-8.963555,"median":-4.721194,"eighty":-0.95209,"marketCap":132875744},{"date":"2026-01-09","current":-4.929603,"twenty":-8.963555,"median":-4.721194,"eighty":-0.95209,"marketCap":128238685},{"date":"2026-01-16","current":-4.677591,"twenty":-8.963555,"median":-4.689597,"eighty":-0.95209,"marketCap":121682842},{"date":"2026-01-23","current":-4.75135,"twenty":-8.963555,"median":-4.672184,"eighty":-0.95209,"marketCap":123601625},{"date":"2026-01-30","current":-4.431725,"twenty":-8.963555,"median":-4.620833,"eighty":-0.95209,"marketCap":115286897},{"date":"2026-02-06","current":-4.062927,"twenty":-8.890146,"median":-4.586033,"eighty":-0.95209,"marketCap":105692981}],"updateTime":1770708390412},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRCA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610658733","title":"Verrica Pharmaceuticals Launches YCANTH in Japan with Torii Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2610658733","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610658733?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:02","pubTimestamp":1770642165,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. has expanded its international presence through a partnership with Torii Pharmaceutical Co. Ltd., resulting in the launch of YCANTH for the treatment of molluscum contagiosum in Japan. As part of this collaboration, Verrica has initiated a manufacturing transfer process to Torii for YCANTH applicators, a transition expected to take several years. During this period, Verrica will supply applicators to Torii and receive a transfer price, eventually moving to a royalty-based model once manufacturing is established in Japan. This development follows the approval of YCANTH in Japan by the Ministry of Health, Labour and Welfare, underscoring Verrica’s commitment to expanding its global footprint and addressing unmet needs in dermatology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL3SzJCc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","LU2210150020.SGD","NDAQ","BK4112","BK4588","BK4585","IE00B3QW5Z07.USD","VRCA","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014005.SGD","BK4007"],"gpt_icon":0},{"id":"2610581516","title":"Verrica Pharmaceuticals Announces Launch of Ycanth® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2610581516","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610581516?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:00","pubTimestamp":1770642004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUA25GLCL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2606267362","title":"Verrica Pharmaceuticals Files Initial Beneficial Ownership Statement for BKB Growth Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2606267362","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606267362?lang=en_us&edition=fundamental","pubTime":"2026-01-27 05:24","pubTimestamp":1769462679,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. has filed an initial statement of beneficial ownership, disclosing BKB Growth Investments, LLC as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL6N2R6j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Verrica Pharmaceuticals Files Initial Beneficial Ownership Statement for BKB Growth Investments","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2601946806","title":"BRIEF-Verrica Pharmaceuticals Announces First Patient Dosed In Phase 3 Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2601946806","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601946806?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:58","pubTimestamp":1767794280,"startTime":"0","endTime":"0","summary":"BRIEF-Verrica Pharmaceuticals Announces First Patient Dosed In Phase 3 Program Jan 7 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O:VERRICA PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN PHASE 3 PRO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA551DY9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2601039198","title":"Verrica Pharmaceuticals Doses First Patient in Phase 3 Trial of YCANTH for Common Warts","url":"https://stock-news.laohu8.com/highlight/detail?id=2601039198","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601039198?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:00","pubTimestamp":1767790839,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. has announced the initiation of a global Phase 3 clinical program evaluating YCANTH  for the treatment of common warts. The first patient was dosed in December 2025. The Phase 3 trial follows positive results from the Phase 2 COVE-1 study, in which 51% of subjects in one cohort achieved complete clearance of all treatable warts at Day 84. Adverse events were primarily local cutaneous reactions, with no serious adverse events reported. The results of the Phase 3 trial have not yet been presented and will be available in the future. Verrica holds global rights to YCANTH for all indications outside of Japan, and the company estimates that common warts represent a multibillion-dollar market opportunity due to the lack of FDA-approved prescription therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for inform","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL5QlW1G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BKPKM429.USD","SG9999014005.SGD","LU2095319765.USD","IE00B64PRP62.GBP","LU2210149790.SGD","NDAQ","VRCA","BK4112","BK4585","SG9999014039.USD","LU2210150020.SGD","BK4007","SG9999014013.SGD","LU0314104364.USD"],"gpt_icon":0},{"id":"2601039648","title":"Verrica Pharmaceuticals Inc - Torii to Fund First $40 Mln of Phase 3 Trial Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2601039648","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601039648?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:00","pubTimestamp":1767790805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA551DY9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2601036778","title":"Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating Ycanth® (Vp-102) for the Treatment of Common Warts","url":"https://stock-news.laohu8.com/highlight/detail?id=2601036778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601036778?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:00","pubTimestamp":1767790805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA551DY9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2595794189","title":"Verrica Pharmaceuticals Files Initial Beneficial Ownership Statement for Director Charles Frantzreb","url":"https://stock-news.laohu8.com/highlight/detail?id=2595794189","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595794189?lang=en_us&edition=fundamental","pubTime":"2025-12-30 20:06","pubTimestamp":1767096386,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Charles Frantzreb as the beneficial owner in the role of Director. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL4SRYR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Verrica Pharmaceuticals Files Initial Beneficial Ownership Statement for Director Charles Frantzreb","news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2595799407","title":"Verrica Pharmaceuticals Grants New Equity Awards to Executives Under 2018 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2595799407","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595799407?lang=en_us&edition=fundamental","pubTime":"2025-12-30 19:06","pubTimestamp":1767092762,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. has announced new equity compensation grants for its senior management. On December 23, 2025, the Compensation Committee approved the grant of options to purchase 512,269 shares of common stock to President and CEO Jayson Rieger, with an exercise price of $8.21 per share, matching the closing price on the grant date. The Committee also approved a grant of 10,000 fully vested restricted stock units to Interim Chief Financial Officer John Kirby. These grants were made under the company's 2018 Equity Incentive Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and R","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDL1fDyPf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2591846029","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2591846029","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591846029?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:50","pubTimestamp":1765889424,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics  shares were 39% lower pre-bell Tuesday, paring Monday's rally.Lightwave Logic  stock was down 19% after the company said late Monday it priced an underwritten offering of 11.7 million common shares for gross proceeds of about $35 million.Ascent Solar Technologies  shares were 13% lower, shaving gains from the previous session.Verrica Pharmaceuticals  stock was down 12%, adding to losses from the previous session.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ASTI","BK4007","BK4148","RADX","BK4139","LWLG","BK4141","VRCA"],"gpt_icon":0},{"id":"2586400526","title":"Verrica Pharmaceuticals CMO Noah L. Rosenberg Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586400526","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586400526?lang=en_us&edition=fundamental","pubTime":"2025-11-26 08:00","pubTimestamp":1764115253,"startTime":"0","endTime":"0","summary":"Noah L. Rosenberg, Chief Medical Officer of Verrica Pharmaceuticals Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL2dfrJ3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2586006544","title":"Director and 10% Owner Paul B. Manning Reports Acquisition of Verrica Pharmaceuticals Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586006544","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586006544?lang=en_us&edition=fundamental","pubTime":"2025-11-26 08:00","pubTimestamp":1764115248,"startTime":"0","endTime":"0","summary":"Paul B. Manning, a Director and 10% Owner, reported the acquisition of common shares of Verrica Pharmaceuticals Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL8JmCNj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2586005274","title":"Verrica Pharmaceuticals CEO Jayson Rieger Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586005274","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586005274?lang=en_us&edition=fundamental","pubTime":"2025-11-26 08:00","pubTimestamp":1764115245,"startTime":"0","endTime":"0","summary":"Jayson Rieger, CEO and President of Verrica Pharmaceuticals Inc., reported an acquisition of common shares of Verrica Pharmaceuticals Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL4ZQz6c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2586400528","title":"Interim CFO John J. Kirby Acquires Common Shares of Verrica Pharmaceuticals Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2586400528","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586400528?lang=en_us&edition=fundamental","pubTime":"2025-11-26 08:00","pubTimestamp":1764115243,"startTime":"0","endTime":"0","summary":"John J. Kirby, Interim CFO of Verrica Pharmaceuticals Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL7hzBdL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Interim CFO John J. Kirby Acquires Common Shares of Verrica Pharmaceuticals Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2586491049","title":"BRIEF-Verrica Pharmaceuticals Enters Securities Purchase Agreement With Institutional Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2586491049","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586491049?lang=en_us&edition=fundamental","pubTime":"2025-11-25 02:17","pubTimestamp":1764008243,"startTime":"0","endTime":"0","summary":"BRIEF-Verrica Pharmaceuticals Enters Securities Purchase Agreement With Institutional InvestorsNov 24  - Verrica Pharmaceuticals Inc VRCA.O:VERRICA PHARMACEUTICALS INC - ENTERS SECURITIES PURCHASE AGREEMENT WITH INSTITUTIONAL INVESTORS - SEC FILINGVERRICA PHARMACEUTICALS INC - TO SELL 6.5 MILLION SHARES IN PRIVATE PLACEMENT - SEC FILINGSource text: [ID:n0001193125-25-292155]Further company coverage: VRCA.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nFWN3X00F5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2586496152","title":"Verrica Pharmaceuticals Inc - Enters Securities Purchase Agreement With Institutional Investors - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586496152","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586496152?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:20","pubTimestamp":1764001232,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nFWN3X00F5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2586151496","title":"Verrica Pharmaceuticals Inc - to Sell 6.5 Mln Shares in Private Placement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586151496","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586151496?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:20","pubTimestamp":1764001232,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nFWN3X00F5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2585462508","title":"Verrica Pharmaceuticals Raises $50 Million in Private Placement Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2585462508","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585462508?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:00","pubTimestamp":1763989222,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. has announced a private investment in public equity  financing, raising approximately $50 million in gross proceeds before placement agent fees and offering expenses. The financing is anchored by Caligan Partners LP and PBM Capital, along with participation from new and existing investors. Caligan Partners will be entitled to designate a new member to Verrica's Board of Directors. Verrica intends to use $35 million of the net proceeds to fully repay its outstanding obligations under its Credit Agreement with OrbiMed, with the remainder allocated to working capital and general corporate purposes. The financing is expected to close on or about November 25, 2025, subject to customary closing conditions. With the proceeds from this financing and existing cash, Verrica expects to fund its operations into mid-2027. TD Cowen is acting as the sole placement agent for the PIPE financing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL4J6Zg4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","VRCA","LU2210149790.SGD","BK4585","IE00BGHQF748.EUR","BK4112","IE00BKPKM429.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","BK4007","NDAQ","LU2095319765.USD","BK4588"],"gpt_icon":0},{"id":"2585546233","title":"Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2585546233","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585546233?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:00","pubTimestamp":1763989203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nTUA4VM8KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2584983010","title":"Lytix Biopharma reports promising clinical results for ruxotemitide in melanoma and basal cell carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2584983010","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584983010?lang=en_us&edition=fundamental","pubTime":"2025-11-18 14:00","pubTimestamp":1763445652,"startTime":"0","endTime":"0","summary":"Cash and short-term financial investments at Lytix Biopharma AS amounted to NOK 90.0 million as of September 30, 2025. The reported net loss was temporarily increased by a non-cash share option expense of NOK 11.9 million related to a new option program launched in September. During the period, Lytix advanced ruxotemitide toward commercialization through internal work in neoadjuvant melanoma and a partnership with Verrica Pharmaceuticals for the non-surgical treatment of basal cell carcinoma. The company is also expanding into deep-seated tumors with LTX-401, supported by positive pre-clinical data and regulatory feedback, and is developing a strategic plan for further clinical development.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL7VXFbS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}]}}